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Abstract. Osteoarthritis (OA) is a chronic disease of the joints and bones due to 
trauma or other joint-related diseases (secondary). Synovial inflammation 
commonly causes disturbance in joint homeostasis, which is associated with OA. 
Enzymes such as aggrecanase and metalloproteinase generate cartilage damage, 
mediated by tumor necrosis factor (TNF-α) and interleukin (IL)-1. Pro-
inflammatory cytokines, including TNF-α, IL-1β, and IL-6, are responsible for 
regulation of the extracellular matrix, cartilage degradation, and apoptosis of 
chondrocytes. This study aimed to observe the cell viability and expression level 
of matrix metalloproteinases (MMP-1 and MMP-3) and tissue inhibitor 
metalloproteinases (TIMP-1 and TIMP-2) in human chondrocyte cells (CHON-
002) induced by IL-1β. CHON-002 was induced with IL-1β (0.1, 1 and 10 
ng/mL) as an OA model. The viability of the cells was measured with a 3-(4,5-
dimethylthiazol-2-yl)-5-(3-carboxyme-thoxyphenyl)-2-(4-sulfophenyl)-2H-tetra 
zolium (MTS) assay, while expression of MMP-1, MMP-3, TIMP-1, and TIMP-
2, was evaluated by RT-PCR. The viability of IL-1β-induced CHON-002 
(CHON-002- IL-1β) cells at day 1 and 5 showed that treatment with up to 10 
ng/mL of IL-1β was not toxic. Expression of TIMP-1 and TIMP-2 in CHON-
002-IL-1β was lower compared to control, while that of MMP-1 and MMP-3 
was higher compared to control. These results indicate that CHON-002 treated 
with 10 ng/mL IL-1β has expression patterns consistent with chondrocyte 
damage, so the CHON-002-IL-1β system may serve as a model for MMP 
induction in OA. 
Keywords: interleukin; mesenchymal stem cell; metalloproteases; MMP genes; 
osteoarthritis. 
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1 Introduction 
The Osteoarthritis (OA) is a chronic disease of the joints and bones due to 
trauma or other joint-related diseases [1]. OA is also associated with synovial 
inflammation, which causes disturbance of joint homeostasis [2]. Until now, an 
effective pharmacotherapy that can repair the function and the original structure 
of the damaged articular cartilage has not been found. Current therapies for OA 
use anti-inflammatory medication such as nonsteroidal anti-inflammatory drugs 
(NSAIDs). Biological therapies for OA and other orthopedic disorders are still 
being investigated [3]. Mesenchymal stem cells (MSCs) have been selected for 
OA therapy, because they are able to differentiate into chondrocytes and have 
the ability to repair articular cartilage. MSCs can be isolated from various types 
of mature tissue without reducing the potency of differentiation [3]. The aim of 
this research was to find an OA cell line model that can be used on treatment 
with MSCs in OA therapy. 
In this research, human chondrocyte cells (CHON-002) were treated with IL-1β 
as a model of OA. IL-1β also promotes OA occurrence through several 
mechanisms: imbalance between damage and recovery of cartilage, reactive 
oxygen species (ROS), including nitrite oxide (NO), and inflammatory 
mediators such as prostaglandin E2 (PGE-2) through increasing of 
cyclooxygenase-2 (COX-2) and inducible nitric oxide synthase (iNOS) [4]. Free 
radicals induce oxidative stress, which can lead to an imbalance in both pro-
oxidants and antioxidants, which further results in joint damage in patients with 
OA and rheumatoid arthritis (RA) [5].  
Matrix metalloproteinases (MMPs) play a major role in the processes of 
chondrolysis. They are responsible for degenerative changes in the OA cartilage 
[6,7]. The messenger RNA (mRNA) identified in human cartilage, based on 
recent studies, comprises MMP-1, MMP-3, MMP-9, and MMP-13 [8,9], type II 
collagen degradation products by collagenase and also specific MMP proteins 
[10-12]. This type of enzyme is related to an intrinsic chondrocyte-mediated 
degenerative change of the cartilage matrix in OA. However, the importance of 
these enzymes remains unclear. The activities of metalloproteinase can be 
inhibited by an endogenous metalloproteinase inhibitor, i.e. tissue inhibitors of 
metalloproteinases (TIMPs) [13]. The complex regulation of MMP production 
by chrondrocytes is affected by several factors, one of which is their response to 
proinflammatory cytokines, including IL-1β or TNF-α [14-18]. This study was 
aimed at observing the levels of MMP-1 and MMP-3 and their inhibitors, 
TIMP-1 and TIMP-2, in CHON-002 induced by IL-1β. 
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2 Materials and Methods 
2.1 Cell Culture 
Human long bone cartilage (CHON-002 ATCC ® CRL-2847™) was obtained 
from Aretha Medika Utama, Biomolecular and Biomedical Research Center, 
Bandung, Indonesia. The cells were cultured and maintained in Dulbecco’s 
Modified Eagle Media (DMEM, Gibco 11995065) supplemented with 10% 
(v/v) fetal bovine serum (FBS, Gibco 10270106), 1% anti-biotic and anti-
mycotic (Gibco, 152400620) and 1% geneticin (Gibco, 10151027), and 
incubated in a humidified atmosphere at a temperature of 37 ºC in 5% CO2 [18]. 
2.2 Induction with IL-1β 
CHON-002 cells (106 cells) were seeded into T-25 flasks and incubated for 2-3 
days. Based on a cytotoxicity assay, the viability results for various 
concentrations showed that the IL-1β was not toxic. Thus, a concentration 
between 5 and 10 ng/mL is safe and was used for the treatment in this study. 
The medium was replaced with media containing 5 or 10 ng/mL recombinant 
IL-1β (Biolegend, 579404). The cells were induced for 5 days [18]. 
2.3 Cytotoxicity Testing for Viability of CHON-002 Cells after 
IL-1β Induction 
CHON-002 cells at 80% confluency were washed with 1 mL of 1x phosphate 
buffered saline (PBS, Gibco 14200075) twice. Then, the cells were added with 
1 mL of Trypsin-EDTA 0.25% (Gibco, 25200072) and incubated at 37 °C in 
5% CO2 for 10 min to remove attached cells. One mililiter of complete medium 
was then added to stop trypsin digestion. The suspension was centrifuged for 5 
min at 1500 rpm. The supernatant was removed and the pellet was homogenized 
with 1 mL of complete medium. The cells were counted with a haemacytometer 
after 10x dilution. The cells were plated at 5000 cells/well for 100 µL medium. 
The cells were added into a 96-well plate and then incubated in 5% CO2 at 37 
°C for 24 h. Medium was removed and added with 90% fresh complete medium 
and 10% of IL-1β. The cells were incubated at 37 °C in 5% CO2 for 24 hours, 
each well was added with 20 µL of 3-(4,5-dimethylthiazol-2-yl)-5-(3-
carboxyme-thoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium (MTS) (Abcam, 
ab197010), and the plate was incubated in 5% CO2 for 3 h at 37 °C. Absorbance 
was measured at 490 nm wavelength using a microplate reader (Thermo 
Scientific Multiskan Go) [19]. 
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2.4 RNA Extraction and cDNA Synthesis 
RNA extraction was done using an Aurum Total RNA Kit (Bio-Rad, 7326820) 
based on the manufacturer’s instructions. Afterwards, the purity of the RNA 
was measured by spectrophotometry at 260/280 nm with a Thermo Scientific 
Multiskan Go. Then, the obtained RNA was used for cDNA synthesis using an 
iScript  cDNA synthesis kit (Bio-Rad, 1708890) for 5 min at 25 °C, 30 min at 
42 °C, and in the last step for 5 min at a temperature of 85 °C. The product 
obtained was stored at -20 °C [20]. 
2.5 mRNA Level Quantification of TIMP-1, TIMP-2, MMP-1, 
and MMP-3 Genes 
Table 1 shows the primer used in this study. Real-time qPCR was done using a 
PikoReal Real-time PCR System (Thermo Scientific Inc.) with pre-incubation 
for 5 min at a temperature of 95 °C, continued with 40 cycles of denaturation 
for 1 min at 95 °C, with the following annealing temperatures: TIMP-1 and 
TIMP-2 at 50 °C, MMP-1 at 54 °C and MMP-3 at 52 °C for 40 sec, and 
elongation for 1 min at 72 °C. The reaction mix that was used to perform qPCR 
was Evagreen Master Mix (Bio-Rad, 1725200) [20]. 
Table 1 Primer sequences. 
Primer Forward Reverse 
β actin 5’-TCTGGCACCACACCTTCTACAATG-3’ 5’-AGCACAGCCTGGATAGCAACG-3’ 
MMP-1 5’-CTGAAGGTGATGAAGCAGCC-3’ 5’-AGTCCAAGAGAATGGCCGAG-3’ 
MMP-3 5’-CTCCACGAGCTTGTAGGAAAG-3’ 5’-CACGCCTGAAGGAAGAGATG-3’ 
TIMP-1 5’-AGTCAAGACCACCTTATACCA-‘3 5’-AGTCAACCAGACCACCTTATACCA-3’ 
TIMP-2 5’-GGAAGTGGACTCTGGAAACGACATT-3’ 5’-CTCGATGTCGAGAAACTCCTGCTTG-3’  
2.6 Statistical Analysis 
The statistical analysis in this study was conducted using SPSS ver. 16.0 with 
one-way analysis of variance (ANOVA). The analysis was continued with 
Duncan tests with significancy p < 0.05. The data in this study are presented as 
mean ± SD. 
3 Results 
3.1 Viability of CHON-002-IL-1β 
The viability of IL-1β-induced CHON-002 cells (CHON-002-IL-1β) was 
measured using an MTS assay. The assay was based on the formation of purple 
formazan product from yellow tetrazolium [19]. The cell viability values of the 
treated cells were compared to control. As can be seen in Table 2, CHON-002-
IL-1β on days 1 and 5 showed that the various concentrations of IL-1β (0.1, 1 
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and 10 ng/mL) and the period of incubation (1 and 5 days) were not toxic. The 
percentage of viable cells that were given IL-1β showed over 100% live cells 
and higher IL-1β concentrations showed increased cell viability. 
Table 2 Viability of CHON-002 cells treated with different concentrations of 
IL-1β and periods of incubation. 
Concentration of 
IL-1β 
Cell viability (%) 
Day 1 incubation Day 5 incubation 
Control  100 ± 13 100 ± 25a 
0,1 ng/mL IL-1β 101 ± 14 98 ± 8a 
1 ng/mL IL-1β 105 ± 14 107 ± 4a 
10 ng/mL IL-1β 112 ± 15 125 ± 12b 
Note: Data are presented as mean ± STD from 3 replications. Superscript letters (a & b) show 
significant differences between treatment (concentration level of IL-1β) on day 5 of incubation 
based on Duncan’s post hoc test with significancy p < 0.05. 
3.2 Characterization of CHON-002-IL-1β 
Degenerative changes in OA cartilage are affected by chondrolytic processes 
that involve MMPs. In this study, the levels of MMP-1 and MMP-3 and its 
inhibitors, TIMP-1 and TIMP-2, were measured in osteoarthritis-like 
characteristics of IL-1β-induced CHON-002 cells. The levels of TIMP-1 and 
TIMP-2 in the IL-1β-induced cells were lower than in control. Meanwhile, 
MMP-1 and MMP-3 were higher in the IL-1β-induced cells compared to the 
control cells, which indicates chondrocyte damage (Figure. 1). 
 
Figure 1 Levels of mRNA expression of MMP-1, MMP-3, TIMP-1 and TIMP-
2 genes in IL-1β-induced CHON-002. The data were analyzed with ANOVA and 
Duncan’s post hoc test. The letters (a,b,c) indicate significant differences 
between treatments (p < 0.05) for each parameter (MMPs and TIMPs). 
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4 Discussion 
In this study, IL-1β was not toxic to the cell line, as indicated by cell viability 
above 100% after treatment. This result is not consistent with previous research, 
where IL-1β caused cell death by apoptosis and necrosis. Cell death caused by 
apoptosis was observed in human chondrocytes in normal OA cartilage after 
incubation with human IL-1β and after ROS-mediated necrosis was suppressed 
[21]. 
In the current study, the levels of MMP-1 and MMP-3 were increased in 
CHON-002-cells treated with 10 ng/mL IL-1β, while the levels of its inhibitors, 
TIMP-1 and TIMP-3, were decreased. Several previous studies, both in vivo 
and in vitro, have shown the role of MMPs in cartilage damage [22-24]. 
Elevated levels of MMP-1 (collagenase-1) and MMP-3 (stromelysin-1) were 
documented in osteoarthritic cartilage [25,26] and also found in the synovial 
fluid of osteoarthristic joints [26,27]. TIMPs are known to block collagenolysis 
effectively, which indicates a role in the inhibition of MMPs in this process, 
while aggrecanolysis is blocked by TIMP-3 [28], probably by inhibition of 
ADAMTS-4 and -5 [29]. 
Cartilage matrix degradation is considered a result of increased activity of 
chondrocyte-produced enzymes. The cartilage breakdown involves various 
kinds of cytokines, while OA chondrocytes are able to synthesize IL-6, IL-1β, 
TNF-α, and many other enzymes [9,15]. MMP synthesis has been up-regulated 
by the proinflamatory cytokines TNF-α and IL-1 β by chondrocytes under 
normal and pathologic conditions [9,18]. Several studies have reported 
measurable levels of cytokines, such as IL-1β and TNF-α, in synovial fluids 
found in normal and diseased joints, contributing to expression of MMP by 
chondrocytes [30]. Referring to previous studies, IL-1β and TNF-α can be 
produced by human chondrocytes in situ and synthesis of these cytokines by 
local chondrocytes can be an alternative source of MMP induction in OA 
cartilage [31]. 
5 Conclusion 
Although apoptotic and necrotic mechanisms can cause cell death, up to 10 
ng/mL IL-1β is not toxic to CHON-002 cells. Since this level of IL-1β increased 
MMP-1 and MMP-3 expression and decreased TIMP-1 and TIMP-2 expression, 
CHON-002-IL-1β may be a useful model for this aspect of OA. 
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